Physician profile
Jp Kim
NPI 1184814428
$7,020.33
in general payments reported to CMS, 2019-2025
14 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $22.74 · 2021: $628 · 2022: $1,294 · 2023: $3,170 · 2024: $523 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,753 · Travel and Lodging: $4.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,752.82 |
| Travel and Lodging | $4.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,477.26 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $1,267.61 | 2022-2025 | Miebo, Biotrue One Day, Xiidra |
| Coopervision INC. | $1,099.46 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Abbvie INC. | $731.47 | 2023-2024 | |
| Glaukos Corporation | $563.96 | 2023 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished) |
| Sun Pharmaceutical Industries INC. | $361.87 | 2022-2023 | Cequa |
| Tarsus Pharmaceuticals, INC. | $359.15 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $358.40 | 2019-2021 | |
| New World Medical,INC. | $237.25 | 2023 | |
| Alcon Vision LLC | $184.05 | 2022-2023 | Total30 |
| Apellis Pharmaceuticals, INC. | $121.24 | 2023 | |
| Novartis Pharmaceuticals Corporation | $114.11 | 2019-2022 | |
| Allergan, INC. | $107.93 | 2022 | |
| Rxsight INC | $36.57 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jp Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.